BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2012

  October 26, 2012

   · 

  1 min read
• Policy

  Watson Pharmaceuticals, Inc. Confirms FDA Denies Appeal Related to Prochieve NDA

  October 26, 2012

   · 

  1 min read
• Business

  Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results

  October 26, 2012

   · 

  1 min read
• Pharm Country

  Savient Pharmaceuticals, Inc. to Hold Third Quarter 2012 Financial Results Conference Call on Thursday, November 8, 2012

  October 26, 2012

   · 

  1 min read
• Policy

  Boehringer Ingelheim Pharmaceuticals, Inc. to Pay $95 Million to Resolve Drug Promo Case

  October 26, 2012

   · 

  1 min read
• Pharm Country

  Unilife Corporation to Announce Financial Results for Fiscal 2013 First Quarter on Tuesday, October 30, 2012

  October 26, 2012

   · 

  2 min read
• Biotech Bay

  Cepheid to Webcast Upcoming Financial Presentations

  October 26, 2012

   · 

  1 min read
• FDA

  Boehringer Ingelheim Corporation, Eli Lilly and Company Release: EU Approval Granted for Trajenta® (linagliptin) Tablets as Add-on Therapy to Insulin in Adults With Type 2 Diabetes

  October 26, 2012

   · 

  1 min read
• Business

  Omnicell Announces Record Revenue and Profit in Third Quarter 2012

  October 26, 2012

   · 

  1 min read
• Genetown

  bluebird bio Gets $9.3 Million to Expand Blood Disorder Program

  October 26, 2012

   · 

  3 min read